Recent Updates
Recently added Catalysts

REPLY 200

Phase 3

Bradycardia | Unknown | Other |LivaNova PLC|Last Updated: Jul 17, 2013

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
UNCONTROLLED
Total Trials1
Total Enrollment40
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01537718Evaluation of the Performances of the Sleep Disordered Breathing Monitoring Function in PacemakerPHASE3 COMPLETED 40Mar 1, 2012Nov 1, 2012Jul 17, 20135 France, Spain
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Event-based sensitivity of breathing troubles
1 day

Evaluation of this outcome requires measuring the number of ventilation pauses and ventilation reductions detected during the same night using SDB Monitoring function or the reference in-lab PSG (clinical assessment).

Event-based Positive Predictive Value of breathing troubles
1 day

The Event-based Positive Predictive Value (PPV)of breathing troubles is complementary to Sensitivity. It is the proportion of abnormal events appropriately detected by SDB Monitoring function compared to the total number of abnormal events detected by SDB Monitoring function.

Secondary Endpoints
Apnea Index-based Positive Predictive Value
1 day
Apnea Index-based Negative Predictive Value
1 day
Safety based on Adverse events
3 months
Unlock Study Endpoints
Study Design & Arms
AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeDIAGNOSTIC
Treatment Arms
ArmTypeDescription
REPLY 200 implanted patientsEXPERIMENTALREPLY 200 implanted patients
Interventions
NameTypeDescription
REPLY 200DEVICEREPLY 200 pacemaker
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexALL
Healthy VolunteersNo
Study Sites5

Inclusion Criteria: Any patient enrolled in the study must fulfil all of the following criteria: * Patients eligible for implantation of a single or dual-chamber pacemaker according to current available guidelines * Patients who are scheduled for implant of a REPLY 200 SR; or REPLY 200 DR pacemaker...

Countries:FranceSpain
Unlock Eligibility Criteria